EHI
RARE icon

Eagle Health Investments’s Ultragenyx Pharmaceutical RARE Stock Holding History

Eagle Health Investments’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.5M Buy
+884,121
New +$19.9M 3.24% 14
2025
Q4 		– Sell
-697,000
Closed -$21M – 34
2025
Q3 		$21M Buy
697,000
+69,400
+11% +$2.08M 5.5% 7
2025
Q2 		$22.8M Hold
627,600
– – 5.63% 8
2025
Q1 		$22.7M Hold
627,600
– – 5.9% 9
2024
Q4 		$26.4M Buy
627,600
+65,900
+12% +$3.27M 6.47% 7
2024
Q3 		$31.2M Buy
561,700
+37,200
+7% +$1.89M 5.91% 7
2024
Q2 		$21.6M Buy
524,500
+224,800
+75% +$9.6M 3.78% 11
2024
Q1 		$14M Buy
+299,700
New +$14.1M 2.6% 15

Other funds holding RARE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Eagle Health Investments's RARE Position: Q1 2026 in Review

Eagle Health Investments opened a new position in Ultragenyx Pharmaceutical (RARE) in Q1 2026: 884,121 shares worth $18.5M. The stake represents 3.24% of the portfolio and ranks #14 among its holdings. This is a return to the name: Eagle Health Investments previously reported a position in RARE as recently as Q3 2025.

Eagle Health Investments first reported a position in RARE in Q1 2024 and has held it in 8 quarters since. The position peaked at $31.2M in Q3 2024. 296 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • Eagle Health Investments held 884,121 shares of Ultragenyx Pharmaceutical worth $18.5M as of Q1 2026.
  • Ultragenyx Pharmaceutical was a new Eagle Health Investments position in Q1 2026.
  • Ultragenyx Pharmaceutical made up 3.24% of Eagle Health Investments's portfolio in Q1 2026, its #14 holding.
  • Eagle Health Investments first reported a position in Ultragenyx Pharmaceutical in Q1 2024 and has held it in 8 quarters since.
  • Eagle Health Investments's Ultragenyx Pharmaceutical position peaked at $31.2M in Q3 2024.
  • 296 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on Eagle Health Investments's 13F filing for Q1 2026, filed 15 May 2026.